A new trading day began on Monday, with Acrivon Therapeutics Inc (NASDAQ: ACRV) stock price down -3.28% from the previous day of trading, before settling in for the closing price of $2.44. ACRV’s price has ranged from $1.05 to $8.00 over the past 52 weeks.
Healthcare Sector giant saw their annual sales slid by -74.96% over the last five years. Meanwhile, its annual earnings per share averaged 14.36%. With a float of $22.27 million, this company’s outstanding shares have now reached $31.55 million.
Acrivon Therapeutics Inc (ACRV) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Acrivon Therapeutics Inc is 29.43%, while institutional ownership is 48.08%. The most recent insider transaction that took place on Apr 30 ’25, was worth 617,412. In this transaction 10% Owner of this company sold 437,881 shares at a rate of $1.41, taking the stock ownership to the 3,403,025 shares. Before that another transaction happened on May 01 ’25, when Company’s 10% Owner sold 298,886 for $1.34, making the entire transaction worth $400,507. This insider now owns 3,104,139 shares in total.
Acrivon Therapeutics Inc (ACRV) Recent Fiscal highlights
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.54 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.5 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 14.36% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.86% during the next five years compared to -74.96% drop over the previous five years of trading.
Acrivon Therapeutics Inc (NASDAQ: ACRV) Trading Performance Indicators
Here are Acrivon Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 8.75.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.13, a number that is poised to hit -0.49 in the next quarter and is forecasted to reach -2.01 in one year’s time.
Technical Analysis of Acrivon Therapeutics Inc (ACRV)
Analysing the last 5-days average volume posted by the [Acrivon Therapeutics Inc, ACRV], we can find that recorded value of 0.28 million was lower than the volume posted last year of 0.74 million. As of the previous 9 days, the stock’s Stochastic %D was 52.33%.
During the past 100 days, Acrivon Therapeutics Inc’s (ACRV) raw stochastic average was set at 75.81%, which indicates a significant increase from 39.34% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.20 in the past 14 days, which was higher than the 0.16 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.24, while its 200-day Moving Average is $1.81. Now, the first resistance to watch is $2.52. This is followed by the second major resistance level at $2.68. The third major resistance level sits at $2.77. If the price goes on to break the first support level at $2.27, it is likely to go to the next support level at $2.18. Now, if the price goes above the second support level, the third support stands at $2.02.
Acrivon Therapeutics Inc (NASDAQ: ACRV) Key Stats
With a market capitalization of 74.47 million, the company has a total of 31,555K Shares Outstanding. Currently, annual sales are 0 K while annual income is -80,560 K. The company’s previous quarter sales were 0 K while its latest quarter income was -18,230 K.
